Detection of “oncometabolite” 2-hydroxyglutarate by magnetic resonance analysis as a biomarker of IDH1/2 mutations in glioma

[1]  Hong Wu,et al.  Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy , 2012, Journal of Neuro-Oncology.

[2]  I. Gribbestad,et al.  MRS and MRSI guidance in molecular medicine: targeting and monitoring of choline and glucose metabolism in cancer , 2011, NMR in biomedicine.

[3]  K. Kinzler,et al.  Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome , 2011, Proceedings of the National Academy of Sciences.

[4]  Bin Wang,et al.  Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. , 2011, Cancer cell.

[5]  Erwin G. Van Meir,et al.  Exciting New Advances in Neuro‐Oncology: The Avenue to a Cure for Malignant Glioma , 2010, CA: a cancer journal for clinicians.

[6]  Ilwoo Park,et al.  Hyperpolarized 13C magnetic resonance metabolic imaging: application to brain tumors. , 2010, Neuro-oncology.

[7]  S. Gabriel,et al.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.

[8]  R. McLendon,et al.  IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.

[9]  L. Liau,et al.  Cancer-associated IDH1 mutations produce 2-hydroxyglutarate , 2009, Nature.

[10]  Ken Chen,et al.  Recurring mutations found by sequencing an acute myeloid leukemia genome. , 2009, The New England journal of medicine.

[11]  Kun-Liang Guan,et al.  Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α , 2009, Science.

[12]  Erwin G. Van Meir,et al.  Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity. , 2009, Cancer research.

[13]  J. Uhm.  An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2009 .

[14]  L. Chung,et al.  HRMAS 1H‐NMR measured changes of the metabolite profile as mesenchymal stem cells differentiate to targeted fat cells in vitro: implications for non‐invasive monitoring of stem cell differentiation in vivo , 2008, Journal of tissue engineering and regenerative medicine.

[15]  Webster K. Cavenee,et al.  Erratum: The 2007 WHO classification of tumours of the central nervous system (Acta Neuropathol (2007) vol. 114 (97-109)) , 2007 .

[16]  Susan M. Chang,et al.  Three‐dimensional J‐resolved H‐1 magnetic resonance spectroscopic imaging of volunteers and patients with brain tumors at 3T , 2007, Magnetic resonance in medicine.

[17]  John C Gore,et al.  A practical guide to robust detection of GABA in human brain by J-difference spectroscopy at 3 T using a standard volume coil. , 2007, Magnetic resonance imaging.

[18]  B. Mueller,et al.  Proton echo‐planar spectroscopic imaging of J‐coupled resonances in human brain at 3 and 4 Tesla , 2007, Magnetic resonance in medicine.

[19]  D. Toufexis,et al.  Changes of metabolite profile in kainic acid induced hippocampal injury in rats measured by HRMAS NMR , 2007, Experimental Brain Research.

[20]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[21]  Ian Marshall,et al.  Reproducibility of GABA measurements using 2D J-resolved magnetic resonance spectroscopy. , 2007, Magnetic resonance imaging.

[22]  Haitao Chu,et al.  Bivariate meta-analysis of sensitivity and specificity with sparse data: a generalized linear mixed model approach. , 2006, Journal of clinical epidemiology.

[23]  S. Becker,et al.  Determination of membrane protein structure and dynamics by magic-angle-spinning solid-state NMR spectroscopy. , 2005, Journal of the American Chemical Society.

[24]  D. Botstein,et al.  Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Susan M. Chang,et al.  Relationship of MR-derived lactate, mobile lipids, and relative blood volume for gliomas in vivo. , 2005, AJNR. American journal of neuroradiology.

[26]  Jürgen Gallinat,et al.  Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 Tesla , 2004, NeuroImage.

[27]  Erwin G. Van Meir,et al.  Alterations in molecular pathways of diffusely infiltrating glial neoplasms: application to tumor classification and anti-tumor therapy (Review). , 2003, International journal of oncology.

[28]  D. Morvan,et al.  Melanoma tumors acquire a new phospholipid metabolism phenotype under cystemustine as revealed by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy of intact tumor samples. , 2002, Cancer research.

[29]  Erwin G. Van Meir,et al.  Necrogenesis and Fas/APO-1 (CD95) Expression in Primary (de novo) and Secondary Glioblastomas , 1998, Journal of neuropathology and experimental neurology.

[30]  R. Gonzalez,et al.  Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Matthijs Oudkerk,et al.  1H MR Spectroscopy Detection of Lipids and Lactate in Metastatic Brain Tumors , 1996, NMR in biomedicine.